CoChat

Inositol as an add‐on treatment for bipolar depression

Chengappa, Kn Roy, Levine, Joseph, Gershon, Samuel, Mallinger, Alan G, Hardan, Antonio, Vagnucci, Anthony, Pollock, Bruce, Luther, James, Buttenfield, Joan, Verfaille, Steve, Kupfer, David J · 2000 · Bipolar Disorders
Cited by 102

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objective: Inositol is a constituent of the intracellular phosphatidyl inositol (PI) second messenger system, which is linked to various neurotransmitter receptors. Inositol crosses the blood–brain barrier in pharmacological doses, and has shown efficacy in a small double‐blind study of unipolar depression. This pilot study evaluated its potential efficacy and safety in bipolar depression. Methods: Twenty‐four consenting adult men and women with DSM‐IV bipolar depression (bipolar I=21; bipolar II=3) were randomly assigned to receive either 12 g of inositol or d‐glucose as placebo for 6 weeks. Efficacy and safety ratings were done weekly. Thymoleptic medications (lithium, valproate, carbamazepine) in stable doses and at therapeutic levels at study entry were continued unchanged. Results: Two subjects receiving placebo dropped out early due to worsening or non‐adherence to the protocol. Among the 22 subjects who completed the trial, six (50%) of the inositol‐treated subjects responded with a 50% or greater decrease in the baseline Hamilton Depression Rating Scale (HAM‐D) score and a Clinical Global Improvement (CGI) scale score change of ‘much’ or ‘very much’ improved, as compared to three (30%) subjects assigned to placebo, a statistically non‐significant difference. On the Montgomery–Asberg Depression Rating Scale (MADRS), eight (67%) of twelve inositol‐treated subjects had a 50% or greater decrease in the baseline MADRS scores compared to four (33%) of twelve subjects assigned to placebo (p=0.10). Inositol was well tolerated with minimal side effects, and thymoleptic blood levels were unaltered. Conclusions: These pilot data suggest a controlled study with an adequate sample size, and the appropriate rating scale may demonstrate efficacy for inositol in bipolar depression. The tolerability and the ‘natural substance’ aspect of inositol may be particularly appealing to subjects with bipolar depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1034/j.1399-5618.2000.020107.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 102

Metadata

Authors
Chengappa, K. R., Levine, J., Gershon, S., Mallinger, A. G., Hardan, A., Vagnucci, A., Pollock, B., Luther, J., Buttenfield, J., Verfaille, S., & Kupfer, D. J.
Venue
Bipolar Disorders
Publisher
Wiley
Published
2000-03
Volume
2
Issue
1
Pages
47-55
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W2070453180
Cited by
102
References
4
FWCI
2.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inositol as an add‐on treatment for bipolar depression. https://app.cochat.ai/papers/10.1034/j.1399-5618.2000.020107.x
The paper
Chengappa, K. R., Levine, J., Gershon, S., Mallinger, A. G., Hardan, A., Vagnucci, A., Pollock, B., Luther, J., Buttenfield, J., Verfaille, S., & Kupfer, D. J. (2000). Inositol as an add‐on treatment for bipolar depression. Bipolar Disorders. https://doi.org/10.1034/j.1399-5618.2000.020107.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.